Operating Responsibly

Operating Responsibly

Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we collect are used safely, ethically, and responsibly.

Content from this campaign

Illumina Named Top 100 Best Corporate Citizens and Ranked #1 in the Employee Category
SAN DIEGO, May 18, 2022 /3BL Media/ - Illumina has been included for the first time on the 2022 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) performance among the 1,000 largest U.S. public companies. Illumina ranked #62 overall, #6 within our industry, and #1...
May 18, 2022 11:45 AM ET
World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says
By Angelica Peebles Two years into the pandemic that has killed millions and shaken the global economy, the world still lacks a unified effort to detect and fight future outbreaks using genetic tools, said...
May 3, 2022 9:00 AM ET
Illumina Releases Annual Corporate Social Responsibility Report
SAN DIEGO, April 7, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today released its annual Corporate Social Responsibility (CSR) Report, highlighting the company's 2021 environmental, social, and governance (ESG) program and commitment to human health. The report details Illumina's role as a champion for patients,...
Apr 7, 2022 12:45 PM ET
Illumina Earns Gold Class in the S&P Global's 2022 Sustainability Yearbook
Our ESG commitments and actions support our goal for a global health transformation. We’re excited to earn the highest distinction of a Gold Class in the S&P Global's 2022...
Feb 3, 2022 12:15 PM ET
Illumina Named One of America's Most JUST Companies for Third Consecutive Year
We are honored to be recognized as #32 by CNBC and ...
Jan 13, 2022 9:00 AM ET

Pages